[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Jeyakumar Y, Richardson L, Sarma S, Retnakaran R, Kramer CK
Transparent pricing and same-cost dosing make it feel refreshingly straightforward in a crowded field
Overall, use of GLP1-RA compared with the use of DPP-4i was not associated with an increased risk of thyroid cancer (pooled weighted HR 0.81, CI 0.591.12)
For instance, according to the latest International Diabetes Federation (IDF) Diabetes Atlas (2025), approximately 11.1% of adults aged 2079 yearsabout 1 in 9 peopleare living with diabetes globally, and more than 4 in 10 of those individuals remain undiagnosed
(1) Limitations of Use: Coadministration with other exenatide containing products is not recommended